Coya Therapeutics (COYA) FCF Margin (2023 - 2026)
Coya Therapeutics (COYA) reported FCF Margin of 2472.07% for Q1 2026, down 137535.0% on a YoY basis from N/an in Q1 2025, and down 9620.12% sequentially from 25.43% in Q4 2025.
Coya Therapeutics (COYA) FCF Margin (2023 - 2026) Analysis & Trends
Coya Therapeutics (COYA) has 4 years of FCF Margin data on file, last reported at 2472.07% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 137535.0% year-over-year to 2472.07%; the trailing twelve-month figure through Mar 2026 stood at 177.85% (up 23633.0% YoY), and the FY2025 full-year result was 135.16%, up 15434.0% from the prior year.
- FCF Margin declined to 2472.07% in Q1 2026, from 25.43% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 1691.82% in Q1 2024 to a low of 123451.18% in Q4 2024.
- A 4-year average of 14342.72% and a median of 133.23% in 2024 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin sank 12341384 bps in 2024 and jumped 12342575 bps in 2025, its largest moves.
- Tracing COYA's FCF Margin over 4 years: stood at 37.34% in 2023, then plunged by 330535 bps to 123451.18% in 2024, then soared by 100 bps to 25.43% in 2025, then plunged by 9620 bps to 2472.07% in 2026.
- Business Quant data shows COYA's FCF Margin at 2472.07% in Q1 2026, 25.43% in Q4 2025, and 31.72% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Coya Therapeutics | 97.14 Mn | 46.42 Mn | - | -2,472.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,472.07% |
| Dec 31, 2025 | -25.43% |
| Sep 30, 2025 | -31.72% |
| Jun 30, 2025 | -3,528.56% |
| Mar 31, 2025 | -1,096.72% |
| Dec 31, 2024 | -123,451.18% |
| Jun 30, 2024 | -133.23% |
| Mar 31, 2024 | 1,691.82% |
| Dec 31, 2023 | -37.34% |